Roivant and Pharvaris surge to record highs on positive trial results
Roivant Sciences (ROIV) and Pharvaris (PHVS) hit all-time highs after reporting positive results for experimental therapies across different trial phases. ROIV was up more than 20% and PHVS was up nearly 8%.